| UniProt ID | GGA3_HUMAN | |
|---|---|---|
| UniProt AC | Q9NZ52 | |
| Protein Name | ADP-ribosylation factor-binding protein GGA3 | |
| Gene Name | GGA3 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 723 | |
| Subcellular Localization |
Golgi apparatus, trans-Golgi network membrane Peripheral membrane protein . Endosome membrane Peripheral membrane protein . |
|
| Protein Description | Plays a role in protein sorting and trafficking between the trans-Golgi network (TGN) and endosomes. Mediates the ARF-dependent recruitment of clathrin to the TGN and binds ubiquitinated proteins and membrane cargo molecules with a cytosolic acidic cluster-dileucine (AC-LL) motif.. | |
| Protein Sequence | MAEAEGESLESWLNKATNPSNRQEDWEYIIGFCDQINKELEGPQIAVRLLAHKIQSPQEWEALQALTVLEACMKNCGRRFHNEVGKFRFLNELIKVVSPKYLGDRVSEKVKTKVIELLYSWTMALPEEAKIKDAYHMLKRQGIVQSDPPIPVDRTLIPSPPPRPKNPVFDDEEKSKLLAKLLKSKNPDDLQEANKLIKSMVKEDEARIQKVTKRLHTLEEVNNNVRLLSEMLLHYSQEDSSDGDRELMKELFDQCENKRRTLFKLASETEDNDNSLGDILQASDNLSRVINSYKTIIEGQVINGEVATLTLPDSEGNSQCSNQGTLIDLAELDTTNSLSSVLAPAPTPPSSGIPILPPPPQASGPPRSRSSSQAEATLGPSSTSNALSWLDEELLCLGLADPAPNVPPKESAGNSQWHLLQREQSDLDFFSPRPGTAACGASDAPLLQPSAPSSSSSQAPLPPPFPAPVVPASVPAPSAGSSLFSTGVAPALAPKVEPAVPGHHGLALGNSALHHLDALDQLLEEAKVTSGLVKPTTSPLIPTTTPARPLLPFSTGPGSPLFQPLSFQSQGSPPKGPELSLASIHVPLESIKPSSALPVTAYDKNGFRILFHFAKECPPGRPDVLVVVVSMLNTAPLPVKSIVLQAAVPKSMKVKLQPPSGTELSPFSPIQPPAAITQVMLLANPLKEKVRLRYKLTFALGEQLSTEVGEVDQFPPVEQWGNL | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 8 | Phosphorylation | MAEAEGESLESWLNK CCCHHHHHHHHHHHH | 48.57 | 28348404 | |
| 15 (in isoform 1) | Ubiquitination | - | 55.18 | 21890473 | |
| 15 | Ubiquitination | SLESWLNKATNPSNR HHHHHHHHCCCCCCC | 55.18 | 21890473 | |
| 15 | Ubiquitination | SLESWLNKATNPSNR HHHHHHHHCCCCCCC | 55.18 | 21890473 | |
| 15 | Ubiquitination | SLESWLNKATNPSNR HHHHHHHHCCCCCCC | 55.18 | 21890473 | |
| 38 | Ubiquitination | GFCDQINKELEGPQI HHHHHHHHHCCCHHH | 66.36 | - | |
| 53 | Ubiquitination | AVRLLAHKIQSPQEW HHHHHHHHCCCHHHH | 36.51 | - | |
| 95 | Acetylation | RFLNELIKVVSPKYL HHHHHHHHHHCHHHC | 49.56 | 25953088 | |
| 98 | Phosphorylation | NELIKVVSPKYLGDR HHHHHHHCHHHCCHH | 20.75 | - | |
| 100 | Ubiquitination | LIKVVSPKYLGDRVS HHHHHCHHHCCHHHC | 45.67 | 21890473 | |
| 100 (in isoform 1) | Ubiquitination | - | 45.67 | 21890473 | |
| 100 | Acetylation | LIKVVSPKYLGDRVS HHHHHCHHHCCHHHC | 45.67 | 25953088 | |
| 100 | Ubiquitination | LIKVVSPKYLGDRVS HHHHHCHHHCCHHHC | 45.67 | 21890473 | |
| 122 | Phosphorylation | IELLYSWTMALPEEA HHHHHHHHHCCCHHH | 6.14 | 18452278 | |
| 132 (in isoform 2) | Ubiquitination | - | 35.28 | 21890473 | |
| 132 | Ubiquitination | LPEEAKIKDAYHMLK CCHHHHHHHHHHHHH | 35.28 | 21890473 | |
| 135 | Phosphorylation | EAKIKDAYHMLKRQG HHHHHHHHHHHHHCC | 9.63 | 27642862 | |
| 139 | Ubiquitination | KDAYHMLKRQGIVQS HHHHHHHHHCCCCCC | 34.79 | - | |
| 141 (in isoform 2) | Ubiquitination | - | 44.36 | 21890473 | |
| 146 | Phosphorylation | KRQGIVQSDPPIPVD HHCCCCCCCCCCCCC | 40.99 | 28555341 | |
| 147 (in isoform 2) | Ubiquitination | - | 35.58 | 21890473 | |
| 147 | Ubiquitination | RQGIVQSDPPIPVDR HCCCCCCCCCCCCCC | 35.58 | 21890473 | |
| 152 (in isoform 2) | Ubiquitination | - | 8.89 | 21890473 | |
| 155 | Phosphorylation | PPIPVDRTLIPSPPP CCCCCCCCCCCCCCC | 25.28 | 28176443 | |
| 159 | Phosphorylation | VDRTLIPSPPPRPKN CCCCCCCCCCCCCCC | 42.94 | 23401153 | |
| 162 (in isoform 2) | Ubiquitination | - | 69.46 | 21890473 | |
| 162 | Ubiquitination | TLIPSPPPRPKNPVF CCCCCCCCCCCCCCC | 69.46 | 21890473 | |
| 165 (in isoform 1) | Ubiquitination | - | 75.14 | 21890473 | |
| 165 | Ubiquitination | PSPPPRPKNPVFDDE CCCCCCCCCCCCCHH | 75.14 | 21890473 | |
| 165 (in isoform 2) | Ubiquitination | - | 75.14 | 21890473 | |
| 165 | Ubiquitination | PSPPPRPKNPVFDDE CCCCCCCCCCCCCHH | 75.14 | 21890473 | |
| 165 | Ubiquitination | PSPPPRPKNPVFDDE CCCCCCCCCCCCCHH | 75.14 | 21890473 | |
| 169 (in isoform 2) | Ubiquitination | - | 11.76 | 21890473 | |
| 174 (in isoform 1) | Ubiquitination | - | 51.33 | 21890473 | |
| 174 | Ubiquitination | PVFDDEEKSKLLAKL CCCCHHHHHHHHHHH | 51.33 | 21906983 | |
| 176 | Ubiquitination | FDDEEKSKLLAKLLK CCHHHHHHHHHHHHH | 59.60 | - | |
| 180 (in isoform 1) | Ubiquitination | - | 55.08 | 21890473 | |
| 180 | Ubiquitination | EKSKLLAKLLKSKNP HHHHHHHHHHHCCCH | 55.08 | 21890473 | |
| 180 | Ubiquitination | EKSKLLAKLLKSKNP HHHHHHHHHHHCCCH | 55.08 | 21890473 | |
| 183 | Ubiquitination | KLLAKLLKSKNPDDL HHHHHHHHCCCHHHH | 70.58 | - | |
| 185 (in isoform 1) | Ubiquitination | - | 71.55 | 21890473 | |
| 185 | Ubiquitination | LAKLLKSKNPDDLQE HHHHHHCCCHHHHHH | 71.55 | 21906983 | |
| 195 | Ubiquitination | DDLQEANKLIKSMVK HHHHHHHHHHHHHHH | 59.65 | 21890473 | |
| 195 (in isoform 1) | Ubiquitination | - | 59.65 | 21890473 | |
| 195 | Ubiquitination | DDLQEANKLIKSMVK HHHHHHHHHHHHHHH | 59.65 | 21890473 | |
| 198 | Ubiquitination | QEANKLIKSMVKEDE HHHHHHHHHHHHHHH | 42.82 | 21890473 | |
| 198 (in isoform 1) | Ubiquitination | - | 42.82 | 21890473 | |
| 198 | Ubiquitination | QEANKLIKSMVKEDE HHHHHHHHHHHHHHH | 42.82 | 21890473 | |
| 202 (in isoform 1) | Ubiquitination | - | 51.29 | 21890473 | |
| 202 | Ubiquitination | KLIKSMVKEDEARIQ HHHHHHHHHHHHHHH | 51.29 | 21906983 | |
| 210 | Ubiquitination | EDEARIQKVTKRLHT HHHHHHHHHHHHHHC | 49.88 | - | |
| 213 | Ubiquitination | ARIQKVTKRLHTLEE HHHHHHHHHHHCHHH | 56.82 | - | |
| 217 | Phosphorylation | KVTKRLHTLEEVNNN HHHHHHHCHHHHHHH | 40.22 | - | |
| 231 (in isoform 2) | Ubiquitination | - | 4.30 | 21890473 | |
| 258 | Ubiquitination | LFDQCENKRRTLFKL HHHHHHHHHHHHHHH | 22.44 | - | |
| 261 | Phosphorylation | QCENKRRTLFKLASE HHHHHHHHHHHHHHC | 40.35 | 30624053 | |
| 264 (in isoform 1) | Ubiquitination | - | 46.38 | 21890473 | |
| 264 | Ubiquitination | NKRRTLFKLASETED HHHHHHHHHHHCCCC | 46.38 | 22053931 | |
| 267 | Phosphorylation | RTLFKLASETEDNDN HHHHHHHHCCCCCCC | 56.33 | 30624053 | |
| 269 | Phosphorylation | LFKLASETEDNDNSL HHHHHHCCCCCCCCH | 46.25 | 30624053 | |
| 275 | Phosphorylation | ETEDNDNSLGDILQA CCCCCCCCHHHHHHH | 36.27 | 10749927 | |
| 339 | Phosphorylation | LDTTNSLSSVLAPAP CCCCCCCHHHCCCCC | 20.44 | 16135791 | |
| 347 | O-linked_Glycosylation | SVLAPAPTPPSSGIP HHCCCCCCCCCCCCC | 50.35 | OGP | |
| 368 | Phosphorylation | QASGPPRSRSSSQAE CCCCCCCCCCCCCCC | 42.14 | 16135791 | |
| 370 | Phosphorylation | SGPPRSRSSSQAEAT CCCCCCCCCCCCCCC | 35.27 | 25627689 | |
| 371 | Phosphorylation | GPPRSRSSSQAEATL CCCCCCCCCCCCCCC | 25.92 | 25627689 | |
| 372 | Phosphorylation | PPRSRSSSQAEATLG CCCCCCCCCCCCCCC | 34.36 | 25159151 | |
| 388 | Phosphorylation | SSTSNALSWLDEELL CCHHHHHHHCCHHHH | 24.15 | 28464451 | |
| 425 | Phosphorylation | HLLQREQSDLDFFSP HHHHHHHCCCCCCCC | 35.07 | 23401153 | |
| 431 | Phosphorylation | QSDLDFFSPRPGTAA HCCCCCCCCCCCCCC | 21.72 | 30266825 | |
| 473 | O-linked_Glycosylation | PAPVVPASVPAPSAG CCCCCCCCCCCCCCC | 23.67 | 23301498 | |
| 478 | O-linked_Glycosylation | PASVPAPSAGSSLFS CCCCCCCCCCCCHHC | 47.57 | 23301498 | |
| 486 | O-linked_Glycosylation | AGSSLFSTGVAPALA CCCCHHCCCCCCHHC | 28.48 | 23301498 | |
| 529 | O-linked_Glycosylation | LLEEAKVTSGLVKPT HHHHHCCCCCCCCCC | 19.17 | 23301498 | |
| 529 | Phosphorylation | LLEEAKVTSGLVKPT HHHHHCCCCCCCCCC | 19.17 | 23312004 | |
| 530 | Phosphorylation | LEEAKVTSGLVKPTT HHHHCCCCCCCCCCC | 32.87 | 23312004 | |
| 536 | Phosphorylation | TSGLVKPTTSPLIPT CCCCCCCCCCCCCCC | 33.90 | 29978859 | |
| 537 | Phosphorylation | SGLVKPTTSPLIPTT CCCCCCCCCCCCCCC | 36.55 | 25850435 | |
| 538 | Phosphorylation | GLVKPTTSPLIPTTT CCCCCCCCCCCCCCC | 21.86 | 25627689 | |
| 548 | Methylation | IPTTTPARPLLPFST CCCCCCCCCCCCCCC | 24.49 | - | |
| 548 | Dimethylation | IPTTTPARPLLPFST CCCCCCCCCCCCCCC | 24.49 | - | |
| 559 | Phosphorylation | PFSTGPGSPLFQPLS CCCCCCCCCCCCCCC | 22.89 | 26657352 | |
| 572 | Phosphorylation | LSFQSQGSPPKGPEL CCCCCCCCCCCCCCC | 30.32 | 26074081 | |
| 592 | Ubiquitination | HVPLESIKPSSALPV EEEHHHCCCCCCCCE | 48.39 | - |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of GGA3_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of GGA3_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| TS101_HUMAN | TSG101 | physical | 15039775 | |
| ARF1_HUMAN | ARF1 | physical | 11301005 | |
| CLH1_HUMAN | CLTC | physical | 11301005 | |
| RABE1_HUMAN | RABEP1 | physical | 12505986 | |
| VPS18_HUMAN | VPS18 | physical | 16996030 | |
| UBC_HUMAN | UBC | physical | 14660606 | |
| PACS1_HUMAN | PACS1 | physical | 16977309 | |
| ARF6_HUMAN | ARF6 | physical | 20848231 | |
| RABE1_HUMAN | RABEP1 | physical | 12858162 | |
| SYNRG_HUMAN | SYNRG | physical | 12858162 | |
| EPN4_HUMAN | CLINT1 | physical | 12858162 | |
| UBC_HUMAN | UBC | physical | 15966896 | |
| ARF6_HUMAN | ARF6 | physical | 18199687 | |
| UBC_HUMAN | UBC | physical | 15701688 | |
| RABE1_HUMAN | RABEP1 | physical | 16473621 | |
| GGA1_HUMAN | GGA1 | physical | 14638859 | |
| GGA2_HUMAN | GGA2 | physical | 14638859 | |
| MPRI_HUMAN | IGF2R | physical | 11859375 | |
| MPRD_HUMAN | M6PR | physical | 11859375 | |
| MON2_HUMAN | MON2 | physical | 18418388 | |
| UBC_BOVIN | UBC | physical | 20150893 | |
| RNF11_HUMAN | RNF11 | physical | 25195858 | |
| ITCH_HUMAN | ITCH | physical | 25195858 | |
| ARF1_HUMAN | ARF1 | physical | 11950392 | |
| TOLIP_HUMAN | TOLLIP | physical | 15047686 | |
| ARF6_HUMAN | ARF6 | physical | 19327867 | |
| ARF6_HUMAN | ARF6 | physical | 17804820 | |
| CYH2_HUMAN | CYTH2 | physical | 17804820 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...